Parian Global Management’s Neuronetics STIM Stock Holding History

Parian Global Management’s Portfolio STIM Stock Details STIM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q3	$2.64M	Buy	830,273 +112,300	+16%	+$408K	8.59%	4
2022 Q2	$2.3M	Sell	717,973 -238,026	-25%	-$691K	10.55%	4
2022 Q1	$2.9M	Sell	955,999 -463,700	-33%	-$1.57M	5.97%	7
2021 Q4	$6.33M	Buy	1,419,699 +548,080	+63%	+$2.68M	5.08%	6
2021 Q3	$5.72M	Buy	871,619 +373,056	+75%	+$3.58M	3.99%	10
2021 Q2	$7.99M	Sell	498,563 -631,141	-56%	-$8.72M	3.43%	9
2021 Q1	$14M	Buy	+1,129,704	New	+$17.3M	6.39%	5

Other funds holding STIM

Cannell Capital Alta, Wyoming $163M AUM 40.62% 1-Year Est. Return

ACM

Archon Capital Management Seattle, Washington $177M AUM 108.05% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

SAM

Silvercrest Asset Management New York $13.8B AUM 28.39% 1-Year Est. Return

Schroder Investment Management Group London, United Kingdom $122B AUM 29.27% 1-Year Est. Return

MAG

Millrace Asset Group Berwyn, Pennsylvania $98.4M AUM 63.71% 1-Year Est. Return

BGIM

Brandywine Global Investment Management Philadelphia, Pennsylvania $14.9B AUM 20.41% 1-Year Est. Return

FWC

First Washington Corp Seattle, Washington $353M AUM 41.46% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

KLC

Kent Lake Capital Reno, Nevada $222M AUM 18.04% 1-Year Est. Return

Parian Global Management's STIM Position: Q3 2022 in Review

Parian Global Management increased its Neuronetics (STIM) stake by 16% in Q3 2022, buying an estimated $408K and bringing the position to 830,273 shares worth $2.64M. The position accounts for 8.59% of the portfolio, ranked #4.

Parian Global Management first reported a position in STIM in Q1 2021 and has held it in 7 quarters since. The position peaked at $14M in Q1 2021. 76 funds tracked by Wall St. Rank hold STIM as of Q3 2022.

Parian Global Management held 830,273 shares of Neuronetics worth $2.64M as of Q3 2022.
Parian Global Management bought 112,300 Neuronetics shares in Q3 2022, an estimated $408K.
Neuronetics made up 8.59% of Parian Global Management's portfolio in Q3 2022, its #4 holding.
Parian Global Management first reported a position in Neuronetics in Q1 2021 and has held it in 7 quarters since.
Parian Global Management's Neuronetics position peaked at $14M in Q1 2021.
76 funds tracked by Wall St. Rank held Neuronetics as of Q3 2022.

Based on Parian Global Management's 13F filing for Q3 2022, filed 14 Nov 2022.